Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.

This publication has 31 references indexed in Scilit:

• Stereoselectivity at the Calcium Channel
  Journal of Cardiovascular Pharmacology, 1985
• Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain
  Biochemical and Biophysical Research Communications, 1984
• [3H] verapamil binding sites in skeletal muscle tranverse tubule membranes
  Biochemical and Biophysical Research Communications, 1984
• Temperature‐dependent regulation of d‐cis‐[³H]diltiazem binding to Ca²⁺ channels by 1,4‐dihydropyridine channel agonists and antagonists
  FEBS Letters, 1983
• Diltiazem potentiates the negative inotropic action of nimodipine in heart
  Biochemical and Biophysical Research Communications, 1983
• Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells
  Nature, 1983
• Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem
  Biochemical and Biophysical Research Communications, 1982
• The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats
  Life Sciences, 1982
• Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties
  Life Sciences, 1981
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973